nd to a histamine blocker. Cyproheptadine also may be of benefit in patients with malignant carcinoid syndrome who develop anorexia or cachexia Rm. Interferon-alfa (IFNa) has been reported to result in biochemical responses in 40 to 50 percent of gastrointestinal neuroendocrine tumors, including carcinoids. The